AHK-Cu for Hair Growth | One Real Study & What to Check

Q: Is AHK-Cu legal to buy?

In the US it is sold lawfully as a research chemical for non-human use and as a cosmetic ingredient. It is not an approved drug, and no AHK-Cu product has been evaluated by a regulator for hair-growth claims.

AHK-Cu for hair growth rests, at bottom, on a single 2007 laboratory study: human hair follicles in culture grew longer, and the cells that drive follicle growth multiplied. That’s a real finding and a thin foundation — and everything sold on top of it deserves a harder look than the serum ads give it. This guide covers what the research measured, what’s actually for sale, what it costs, and how to verify a vial before any money moves.

What You Need to Know

The core evidence is one ex vivo study. AHK-Cu stimulated human hair follicle elongation and dermal papilla cell proliferation in a dish — at picomolar-to-nanomolar concentrations. No human trial of AHK-Cu for hair regrowth has ever been published.
No dosage exists. Laboratory concentrations are not doses, and no dose-finding study has been run by any route. Reconstitution math is the only exact part — our peptide calculator handles it.
Supply is the weak link. None of the vendors we track stock AHK-Cu; it circulates through cosmetic serum brands and smaller storefronts where COA discipline is thinner. Verification matters more here, not less.
The stocked alternative has the deeper file. GHK-Cu — the other copper tripeptide — carries five decades of research, including follicle-size findings, and is a standard catalog item with batch COAs. The full head-to-head is in our AHK-Cu vs GHK-Cu comparison.
Everything here concerns compounds sold strictly for non-human research use.

Jump to a Section

1. What Is AHK-Cu and Why Hair Researchers Care
2. The Numbers That Matter: What the Studies Measured
3. Is AHK-Cu Legal to Buy?
4. Your Options for Getting AHK-Cu
5. How to Choose a Quality Supplier
6. What It Costs — and the Stocked Alternative
7. Reconstitution, Storage, and the Dose Problem
8. Side Effects: What’s Actually Known
9. AHK-Cu vs Other Hair Peptides
Frequently Asked Questions
Glossary of Terms

1. What Is AHK-Cu and Why Hair Researchers Care

AHK-Cu is the tripeptide L-alanyl-L-histidyl-L-lysine bound to a copper(II) ion. It’s a close structural cousin of GHK-Cu — one amino acid apart — but with a very different history: GHK was isolated from human plasma in 1973 and studied for fifty years (PMID 4349963), while AHK entered the literature as a synthesized compound aimed at one question: what does it do to hair follicles?

The answer that launched a hundred serums came from Seoul National University’s dermatology department in 2007. Their finding — covered in detail in the next section — is why “AHK-Cu” appears on hair products at all. It is also, for all practical purposes, the entire direct evidence base. Understanding exactly what it showed, and what it couldn’t show, is the difference between researching this compound and buying a story about it.

2. The Numbers That Matter: What the Studies Measured

The 2007 study: real follicle effects, in a dish

Pyo and colleagues took human hair follicles maintained ex vivo and cultured dermal papilla cells — the specialized fibroblasts that sit at the base of each follicle and drive its growth — and exposed them to AHK-Cu at concentrations from 10⁻¹² to 10⁻⁹ molar (PMID 17703734). Three results: follicle elongation was stimulated, dermal papilla cell proliferation increased, and at the top concentration the cells’ apoptosis markers shifted toward survival — a raised Bcl-2/Bax ratio and less cleaved caspase-3 — though the drop in the number of dying cells itself was not statistically significant. The authors proposed AHK-Cu promotes follicle growth by boosting papilla cell proliferation and blunting their die-off.

Now the limits, which the serum listings skip: this was isolated tissue in culture medium. No scalps, no photographs, no hair counts, no placebo arm, no follow-up study in the nineteen years since. Picomolar dish concentrations cannot be converted into a serum strength or an injection amount by any honest method.

The 1993 rat result everyone borrows

The older supporting data point involves a related copper-binding peptide, PC1031, which enlarged vellus follicles on fuzzy-rat back skin with an effect the Wisconsin primate-center researchers described as similar to topical minoxidil (PMID 8326148). When a product page says “copper peptides performed like minoxidil in studies,” that rat, that peptide, and that year are what’s being stretched. The same paper is useful for another reason: it shows what real hair-growth measurement looks like — phototrichogram counts and follicular morphometry — which is exactly what the AHK-Cu literature lacks.

What about before-and-after results?

No controlled before-and-after study of AHK-Cu exists — no standardized photography, no hair counts, no placebo arm. What circulates is product-page imagery and user reports, and both belong in the same category: testimonials with lighting. Reports aren’t worthless — they tell you what buyers hope to see and occasionally flag something worth testing — but with no dose control and no blinding, they are hypothesis fuel, not evidence. If a listing shows photos, ask the only question that matters: was the protocol published anywhere a reviewer could check?

What a real answer would require

The bar is not exotic: recruit human scalps, randomize against placebo, run standardized phototrichogram counts over six months. Minoxidil cleared that bar decades ago; no copper peptide has attempted it. Until someone does, “AHK-Cu grows hair” is a hypothesis with one good dish study behind it — worth researching, not worth asserting.

3. Is AHK-Cu Legal to Buy?

In the US, AHK-Cu occupies the same category as other research peptides: not an approved drug, not a scheduled substance, sold lawfully as a research chemical for non-human laboratory use, and additionally blended into cosmetic products under cosmetic-ingredient rules. What that means practically: buying a research vial is legal; every vial is labeled not-for-human-use; and no regulator has evaluated any AHK-Cu product for hair-growth claims. A serum brand making regrowth promises is making cosmetic marketing claims, not reporting an approval.

4. Your Options for Getting AHK-Cu

The market splits into two channels. Cosmetic serums and sprays — hair-care brands selling AHK-Cu (often blended with GHK-Cu) at gram-scale totals per bottle, as leave-in topicals. And research-grade vials — lyophilized AHK-Cu powder from research-chemical storefronts, typically 50–200mg. The channels answer to different rules and different quality floors, and neither has published evidence behind its specific format.

Here’s the part we verify rather than assume: none of the vendors we track and test stocks AHK-Cu as of this writing. The suppliers that do sell it are mostly smaller storefronts we haven’t reviewed, which shifts the burden onto the document covered in the next section. (Disclosure: some links on this site are affiliate links, including the vendor links and price tables below — they don’t change what we report.) Everything in this channel is sold strictly for non-human research use.

5. How to Choose a Quality Supplier

A compound with one supporting study deserves more purity verification, not less — an unverified vial of a barely-studied peptide is two unknowns stacked. The checklist:

Batch-matched COA, not a stock image. The certificate must match the lot number on your vial and state identity and quantity, not just a purity percentage.
The sequence must say AHK. Listings blur AHK-Cu and GHK-Cu constantly. A COA that says “copper peptide” without naming the tripeptide hasn’t identified anything.
Third-party testing beats in-house claims. An independent lab certificate (e.g. Janoshik) with a verifiable report number outranks any vendor-generated PDF.
Beware borrowed evidence. A listing citing “clinical studies” for AHK-Cu is citing a dish study or someone else’s molecule. You now know the whole literature; hold listings to it.

Our vendor reviews walk through what a passing COA looks like in practice.

6. What It Costs — and the Stocked Alternative

Because AHK-Cu sits outside the tested-vendor ecosystem, its pricing is a scatter: cosmetic serums commonly run $30–$80 a bottle, and research vials vary widely between storefronts with no price-tracking we’d stand behind. We won’t print a “typical monthly cost” for a compound whose dose doesn’t exist and whose supply we can’t verify — any such number would be invented twice.

What we can price precisely is the alternative most hair-focused researchers land on. GHK-Cu carries the deeper evidence file — including the follicle-size and hair-transplant findings in its tissue-remodeling literature (PMID 18644225) — and is a standard catalog item with batch COAs from vendors we test. Live prices, updated daily:

Loading price comparison…

The science case for each molecule is laid out in our AHK-Cu vs GHK-Cu comparison and the full GHK-Cu review.

7. Reconstitution, Storage, and the Dose Problem

Let’s be exact about what’s exact. There is no established AHK-Cu dose — not topical, not injected. The one study used dish concentrations; nobody has ever run dose-finding. Any chart on a product page assigning milligrams per day performed that conversion with a keyboard, not an experiment.

The arithmetic, by contrast, has exact answers. A 100mg research vial reconstituted with 2ml of bacteriostatic water holds 50mg per ml — 5mg per 10 units on a U-100 syringe; our peptide calculator runs that conversion for any vial, water volume, and syringe, and deliberately stops short of recommending an amount. Storage follows standard peptide practice: lyophilized powder cool and dark; reconstituted vials refrigerated and used within about four weeks.

Topical or injectable: which format does the evidence support?

Neither, strictly — the study was a dish — but the formats aren’t equal in inference distance. A leave-in topical at least parallels how the broader copper-peptide literature was built, since GHK-Cu’s strongest work is topical. Injectable AHK-Cu stacks two extrapolations: a route no copper-peptide hair study has used, on a molecule with one study total. That’s the same route-versus-evidence gap we map for blends in the KLOW dosage guide, and the reasoning transfers: the further a format drifts from how the research was actually done, the more of the product page is imagination.

8. Side Effects: What’s Actually Known

Here’s a sentence you won’t find on a serum listing: no safety dataset for AHK-Cu exists. We’ve since mapped that absence in full — our AHK-Cu side effects page covers everything that is and isn’t known. The 2007 study measured growth markers in tissue, not tolerability in people; there are no published human trials by any route, so there is no adverse-event table to cite — which is different from evidence of safety. Cosmetic use of copper peptides broadly has a long commercial history, and the best-documented safety-adjacent work belongs to GHK-Cu’s file, not AHK’s. For injected AHK-Cu specifically, the honest summary is that nothing has been measured. A researcher should log that as the risk profile: unknown, not “well tolerated.”

9. AHK-Cu vs Other Hair Peptides

Where does AHK-Cu sit in the hair-research toolbox? Against GHK-Cu: AHK has the more direct follicle study; GHK has fifty years of literature, the follicle-size findings, and the trustworthy supply chain — the full breakdown is in the comparison guide. Against the blend route: GHK-Cu is one quarter of KLOW, and our KLOW-for-hair page maps which component evidence is real there. And against the approved standards — minoxidil and finasteride — no copper peptide has cleared the placebo-controlled human-trial bar those compounds met, which is the context every peptide hair claim should be read in. More evidence-first guides live in our guide library.

Frequently Asked Questions

Does AHK-Cu really work for hair growth?

Unproven. One 2007 study showed AHK-Cu stimulated human hair follicle elongation and dermal papilla cell proliferation ex vivo — real effects in isolated tissue. No human trial has tested whether it grows hair on an actual scalp, so every regrowth promise on a product page outruns the evidence.

Is there an AHK-Cu dosage for hair growth?

No. The only direct study used picomolar-to-nanomolar laboratory concentrations, which cannot be converted into a topical strength or injection amount. No dose-finding study exists by any route; published charts are constructed, not measured.

How long does AHK-Cu take to work?

Unknown — no study has measured time-to-effect in humans. Timelines quoted by serum brands are marketing estimates borrowed from general hair-cycle biology, not AHK-Cu data.

Is AHK-Cu legal to buy?

In the US it’s sold lawfully as a research chemical for non-human use and as a cosmetic ingredient. It is not an approved drug, and no AHK-Cu product has been evaluated by a regulator for hair-growth claims.

How do I know an AHK-Cu vial is real?

Demand a batch-matched certificate of analysis that names the AHK sequence specifically and states quantity — and prefer independent third-party testing with a verifiable report number. Since no vendor we track stocks AHK-Cu, the COA is doing all the quality-control work.

Is GHK-Cu better than AHK-Cu for hair?

No head-to-head study exists. AHK-Cu has the more direct follicle experiment; GHK-Cu has the far larger literature, follicle-size findings, and lab-tested supply. Our comparison guide covers the trade-off in full.

Glossary of Terms

Dermal papilla cells: specialized fibroblasts at the follicle base that regulate hair growth; the cell type AHK-Cu stimulated in vitro.
Ex vivo: living tissue studied outside the body — real human follicles, but in culture, not on a scalp.
Tripeptide-copper complex: a three-amino-acid peptide bound to a copper(II) ion; AHK-Cu and GHK-Cu are the two sold commercially.
COA (certificate of analysis): the lab document identifying a batch’s contents and purity; batch-matched or it proves nothing.
Vellus vs terminal follicles: fine, small follicles versus full-sized ones; “enlargement” findings describe vellus follicles growing toward terminal type.
Phototrichogram: standardized photographic hair-count method — the measurement real regrowth trials use and AHK-Cu studies never have.
Reconstitution: dissolving lyophilized peptide powder in bacteriostatic water before use; pure arithmetic, covered by our calculator.

AHK-Cu for Hair Growth: One Real Study, and What to Buy Instead of a Story